Paper26320194
Association of a Schizophrenia Risk Variant at the DRD2 Locus With Antipsychotic Treatment Response in First-Episode Psychosis.
Zhang JP and 9 others. Schizophr Bull, 2015. Cited by 58 papers, by iCite.
Cite this record
ConductScience Library. Association of a Schizophrenia Risk Variant at the DRD2 Locus With Antipsychotic Treatment Response in First-Episode Psychosis. Papers, record 26320194. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26320194
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antipsychotic Agents | Major topic |
| Aripiprazole | Major topic |
| Outcome Assessment, Health Care | Major topic |
| Psychotic Disorders | Major topic |
| Receptors, Dopamine D2 | Major topic |
| Risperidone | Major topic |
| Schizophrenia | Major topic |
| Adolescent | |
| Adult | |
| Female | |
| Genetic Loci | |
| Humans | |
| Male | |
| Polymorphism, Single Nucleotide | |
| Randomized Controlled Trials as Topic | |
| Risk | |
| Young Adult |
Source PubMed
Grants12
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 MH060004 | NIMH NIH HHS | United States | R01MH060004 | PubMed and NIH | NIH RePORTER |
| R21 MH099868 | NIMH NIH HHS | United States | R21MH099868 | PubMed and NIH | NIH RePORTER |
| P50MH080173 | NIMH NIH HHS | United States | P50MH080173 | PubMed and NIH | NIH RePORTER |
| K23MH100264 | NIMH NIH HHS | United States | K23MH100264 | PubMed and NIH | NIH RePORTER |
| K23 MH097108 | NIMH NIH HHS | United States | K23MH097108 | PubMed and NIH | NIH RePORTER |
| R21MH099868 | NIMH NIH HHS | United States | R21MH099868 | PubMed and NIH | NIH RePORTER |
| P50 MH080173 | NIMH NIH HHS | United States | P50MH080173 | PubMed and NIH | NIH RePORTER |
| P30 MH090590 | NIMH NIH HHS | United States | P30MH090590 | PubMed and NIH | NIH RePORTER |
| K23 MH100264 | NIMH NIH HHS | United States | K23MH100264 | PubMed and NIH | NIH RePORTER |
| K23MH097108 | NIMH NIH HHS | United States | K23MH097108 | PubMed and NIH | NIH RePORTER |
| P30MH090590 | NIMH NIH HHS | United States | P30MH090590 | PubMed and NIH | NIH RePORTER |
| R01MH060004 | NIMH NIH HHS | United States | R01MH060004 | PubMed and NIH | NIH RePORTER |
References30
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20135898 | Pharmacogenetics of antipsychotic-induced side effects. | Dialogues Clin Neurosci | 2009 | https://conductscience.org/library/papers/20135898 | PubMed |
| 2 | 21162693 | Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction. | Expert Opin Drug Metab Toxicol | 2011 | https://conductscience.org/library/papers/21162693 | PubMed |
| 3 | 22584864 | Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents. | Mol Psychiatry | 2012 | https://conductscience.org/library/papers/22584864 | PubMed |
| 4 | 25056061 | Biological insights from 108 schizophrenia-associated genetic loci. | Nature | 2014 | https://conductscience.org/library/papers/25056061 | PubMed |
| 5 | 1681750 | Dopamine in schizophrenia: a review and reconceptualization. | Am J Psychiatry | 1991 | https://conductscience.org/library/papers/1681750 | PubMed |
| 6 | 26338693 | A Randomized Comparison of Aripiprazole and Risperidone for the Acute Treatment of First-Episode Schizophrenia and Related Disorders: 3-Month Outcomes. | Schizophr Bull | 2015 | https://conductscience.org/library/papers/26338693 | PubMed |
| 7 | 11229973 | Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis. | Am J Psychiatry | 2001 | https://conductscience.org/library/papers/11229973 | PubMed |
| 8 | 22529829 | A Practical Guide to Calculating Cohen's f(2), a Measure of Local Effect Size, from PROC MIXED. | Front Psychol | 2012 | https://conductscience.org/library/papers/22529829 | PubMed |
| 9 | 12784105 | Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology. | Neuropsychopharmacology | 2003 | https://conductscience.org/library/papers/12784105 | PubMed |
| 10 | 2574607 | A rating scale for drug-induced akathisia. | Br J Psychiatry | 1989 | https://conductscience.org/library/papers/2574607 | PubMed |
| 11 | 24986384 | A neurobiological hypothesis for the classification of schizophrenia: type A (hyperdopaminergic) and type B (normodopaminergic). | Br J Psychiatry | 2014 | https://conductscience.org/library/papers/24986384 | PubMed |
| 12 | 20923620 | Past and present progress in the pharmacologic treatment of schizophrenia. | J Clin Psychiatry | 2010 | https://conductscience.org/library/papers/20923620 | PubMed |
| 13 | 20513652 | Second-generation antipsychotic drugs and extrapyramidal side effects: a systematic review and meta-analysis of head-to-head comparisons. | Schizophr Bull | 2012 | https://conductscience.org/library/papers/20513652 | PubMed |
| 14 | 20194480 | D2 receptor genetic variation and clinical response to antipsychotic drug treatment: a meta-analysis. | Am J Psychiatry | 2010 | https://conductscience.org/library/papers/20194480 | PubMed |
| 15 | 20714340 | Systematic analysis of dopamine receptor genes (DRD1-DRD5) in antipsychotic-induced weight gain. | Pharmacogenomics J | 2012 | https://conductscience.org/library/papers/20714340 | PubMed |
| 16 | 14642968 | Half a century of antipsychotics and still a central role for dopamine D2 receptors. | Prog Neuropsychopharmacol Biol Psychiatry | 2003 | https://conductscience.org/library/papers/14642968 | PubMed |
| 17 | 26315980 | Baseline Striatal Functional Connectivity as a Predictor of Response to Antipsychotic Drug Treatment. | Am J Psychiatry | 2016 | https://conductscience.org/library/papers/26315980 | PubMed |
| 18 | 22083729 | Pharmacogenetics in psychiatry: translating research into clinical practice. | Mol Psychiatry | 2012 | https://conductscience.org/library/papers/22083729 | PubMed |
| 19 | 10663410 | Atypical antipsychotics: are some more atypical than others? | Psychopharmacology (Berl) | 2000 | https://conductscience.org/library/papers/10663410 | PubMed |
| 20 | 15289815 | Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs. | Mol Psychiatry | 2005 | https://conductscience.org/library/papers/15289815 | PubMed |
Cited by39
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 58 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42022561 | Psychiatric pharmacogenomics: from genetic evidence to clinical integration - structural, educational, and ethical challenges. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42022561 | PubMed |
| 41888498 | Genetic Variations in the Dopaminergic Signaling Pathways and Their Implications for Antipsychotics Pharmacogenetics. | J Mol Neurosci | 2026 | https://conductscience.org/library/papers/41888498 | PubMed |
| 41029371 | Associations of ANKK1 (rs1800497) polymorphism with glucose and lipid metabolism in patients with schizophrenia treated with olanzapine: a retrospective study. | Ann Gen Psychiatry | 2025 | https://conductscience.org/library/papers/41029371 | PubMed |
| 39273318 | Receptor Pharmacogenomics: Deciphering Genetic Influence on Drug Response. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39273318 | PubMed |
| 38421437 | The polymorphisms of candidate pharmacokinetic and pharmacodynamic genes and their pharmacogenetic impacts on the effectiveness of risperidone maintenance therapy among Saudi children with autism. | Eur J Clin Pharmacol | 2024 | https://conductscience.org/library/papers/38421437 | PubMed |
| 38399298 | Clinical Utility and Implementation of Pharmacogenomics for the Personalisation of Antipsychotic Treatments. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/38399298 | PubMed |
| 37880658 | Association of DRD2, DRD4 and COMT genes variants and their gene-gene interactions with antipsychotic treatment response in patients with schizophrenia. | BMC Psychiatry | 2023 | https://conductscience.org/library/papers/37880658 | PubMed |
| 36979877 | Dopamine Dynamics and Neurobiology of Non-Response to Antipsychotics, Relevance for Treatment Resistant Schizophrenia: A Systematic Review and Critical Appraisal. | Biomedicines | 2023 | https://conductscience.org/library/papers/36979877 | PubMed |
| 36551925 | Pharmacogenetics and Schizophrenia-Can Genomics Improve the Treatment with Second-Generation Antipsychotics? | Biomedicines | 2022 | https://conductscience.org/library/papers/36551925 | PubMed |
| 36539584 | Effects of Glycogen Synthase Kinase-3 Beta Gene Polymorphisms on the Plasma Concentration of Aripiprazole in Chinese Patients with Schizophrenia: A Preliminary Study. | J Mol Neurosci | 2023 | https://conductscience.org/library/papers/36539584 | PubMed |
| 36068471 | Pharmacogenetics of Antipsychotic Treatment in Schizophrenia. | Methods Mol Biol | 2022 | https://conductscience.org/library/papers/36068471 | PubMed |
| 34524581 | Impact on the Risk and Severity of Childhood Onset Schizophrenia of Schizophrenia Risk Genetic Variants at the DRD2 and ZNF804A Loci. | Child Psychiatry Hum Dev | 2023 | https://conductscience.org/library/papers/34524581 | PubMed |
| 33866994 | Evidence of an interaction between FXR1 and GSK3β polymorphisms on levels of Negative Symptoms of Schizophrenia and their response to antipsychotics. | Eur Psychiatry | 2021 | https://conductscience.org/library/papers/33866994 | PubMed |
| 32864408 | Correlated expression analysis of genes implicated in schizophrenia: identification of putative disease-related pathways. | New Horiz Transl Med | 2017 | https://conductscience.org/library/papers/32864408 | PubMed |
| 32632502 | Potential pharmacogenomic targets in bipolar disorder: considerations for current testing and the development of decision support tools to individualize treatment selection. | Int J Bipolar Disord | 2020 | https://conductscience.org/library/papers/32632502 | PubMed |
| 32399466 | Pharmacogenetics of Antipsychotic Drug Treatment: Update and Clinical Implications. | Mol Neuropsychiatry | 2020 | https://conductscience.org/library/papers/32399466 | PubMed |
| 31877761 | Pharmacogenomic Characterization in Bipolar Spectrum Disorders. | Pharmaceutics | 2019 | https://conductscience.org/library/papers/31877761 | PubMed |
| 31768374 | No Effect of Genome-Wide Significant Schizophrenia Risk Variation at the DRD2 Locus on the Allelic Expression of DRD2 in Postmortem Striatum. | Mol Neuropsychiatry | 2019 | https://conductscience.org/library/papers/31768374 | PubMed |
| 31522868 | Neurodevelopmental concepts of schizophrenia in the genome-wide association era: AKT/mTOR signaling as a pathological mediator of genetic and environmental programming during development. | Schizophr Res | 2020 | https://conductscience.org/library/papers/31522868 | PubMed |
| 31367015 | Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes. | Nat Genet | 2019 | https://conductscience.org/library/papers/31367015 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| DRD2 | 1813 | PubTator's text mining | https://conductscience.org/library/genes/1813 | NCBI Gene |
| PRL | 5617 | PubTator's text mining | https://conductscience.org/library/genes/5617 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26320194
GET https://conductscience.org/api/papers/v1/26320194/references?page=2